| Literature DB >> 34178032 |
Alexander Diamandas1, Mikhail R Razon1, Sandra Ramirez-Arcos2,3, Ann Karen C Brassinga1.
Abstract
Bacterial contamination of platelet concentrates (PCs) can occur during blood donation or PC processing, necessitating routine screening to identify contaminated products in efforts to prevent adverse transfusion reactions in recipient patients. Serratia marcescens is a common bacterial contaminant, and its resilient nature coupled with genetic promiscuity imbue this environmental bacterium with resistance to disinfectants and antibiotics enhancing bacterial virulence. In this study, we aim to understand adaptive survival mechanisms through genetic characterization of two S. marcescens strains, CBS11 and CBS12, isolated from PCs by Canadian Blood Services. Genomic analyses of the two strains indicated that CBS11 has one chromosome and one plasmid (pAM01), whereas CBS12 has no plasmids. Phylogenetic analyses show that CBS11 and CBS12 are non-clonal strains, with CBS11 clustering closely with clinical strain CAV1492 and less so with environmental strain PWN146, and CBS12 clustering with a clinical strain AR_0027. Interestingly, pAM01 was most closely related to PWN146p1, a plasmid found in S. marcescens PWN146 strain associated with pinewood nematode Bursaphelenchus xylophilus. Lastly, the genomic diversity of CBS11 and CBS12 was not reflected in the antibiotic resistance profiles as they were remarkably similar to one another, but was reflected in the virulence phenotypes assessed in the Caenorhabditis elegans nematode infection model, with CBS11 being more virulent then CBS12. Taken together, we suggest that S. marcescens environmental isolates that feature evolutionary diverse genomics are better equipped to adapt and thrive in varied environments, such as that of PCs, and therefore is as much of a concern as multi-drug resistance for human infection potential.Entities:
Keywords: C. elegans; genomic analyses; platelet concentrates; serratia macrescens; virulence
Year: 2021 PMID: 34178032 PMCID: PMC8222908 DOI: 10.3389/fgene.2021.667062
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
FIGURE 1Tamura Nei Phylogenetic rooted tree (cladogram format) analyses of (A) CBS11 and CBS12 along with eight other known S. marcescens strains [RSC-14 (outgroup), Db11, SM39, CAV1492, WW4, FDAARGOS_65, AR_0027, PWN146]; and (B) pAM01 along with S. marcescens strains [CBS11, CBS12, Db11 (outgroup)] and S. marcescens plasmid PWN146p1. See text for further details.
Published S. marcescens genomes used for phylogenetic comparison.
| Strain or plasmid | GenBank accession number | Isolation source (published reference) |
| AR_0027 | Clinical Isolate (none) | |
| Db11 | Moribund fly ( | |
| RSC–14 | ||
| CAV1492 | Clinical Isolate ( | |
| FDAARGOS_65 | Clinical Isolate (none) | |
| SM39 | Clinical isolate ( | |
| WW4 | Paper machine ( | |
| PWN146 | ||
| PWN146p1 |
Resistance gene identifier hits shared between CBS11 and CBS12 detected as “strict” and hits of pAM01 plasmid detected as “loose”.
| RGI criteria | ARO term | SNP | Detection criteria | AMR gene family | Drug class | Resistance mechanism | % identity | % length |
| Strict | CRP | Protein homolog model | Resistance-nodulation-cell division (RND) antibiotic efflux pump | Macrolide antibiotic, fluoroquinolone antibiotic, penam | Antibiotic efflux | 99.05 | 100.00 | |
| Strict | SRT-2 | Protein homolog model | SRT beta-lactamase | Cephalosporin | Antibiotic inactivation | 98.41 | 100.00 | |
| Strict | AAC(6′)-lc | Protein homolog model | AAC(6′) | Aminoglycoside antibiotic | Antibiotic inactivation | 96.58 | 100.00 | |
| Strict | Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin | R234F | Protein variant model | Elfamycin resistant EF-Tu | Elfamycin antibiotic | Antibiotic target alteration | 95.17 | 96.33 |
| Strict | Escherichia coli EF-Tu mutants conferring resistance to Protein homolog model Pulvomycin | R234F | Protein variant model | Elfamycin resistant EF-Tu | Elfamycin antibiotic | Antibiotic target alteration | 95.17 | 96.33 |
| Strict | Escherichia coli GlpT mutants conferring resistance to fosfomycin | E448K | Protein variant model | Antibiotic resistance GlpT | Fosfomycin | Antibiotic target alteration | 90.87 | 99.56 |
| Strict | Klebsiella pneumoniae KpnH | Protein homolog model | Major facilitator superfamily (MFS) antibiotic efflux pump | Macrolide antibiotic, fluoroquinolone antibiotic, aminoglycoside antibiotic, carbapenem, cephalosporin, penam, peptide antibiotic, penem | Antibiotic efflux | 84.02 | 100.00 | |
| Strict | Klebsiella pneumoniae KpnF | Protein homolog model | Major facilitator superfamily (MFS) antibiotic efflux pump | Macrolide antibiotic, fluoroquinolone antibiotic, aminoglycoside antibiotic, carbapenem, cephalosporin, penam, peptide antibiotic, penem | Antibiotic efflux | 73.39 | 100.00 | |
| Strict | adeF | Protein homolog model | Resistance-nodulation-cell division (RND) antibiotic efflux pump | Fluoroquinolone antibiotic, tetracycline antibiotic | Antibiotic efflux | 60.1 | 98.87 | |
| Strict | Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics | D350N | Protein variant model | Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics | Cephalosporin, cephamycin, penam | Antibiotic target alteration | 52.91 | 96.23 |
| Strict | adeF | Protein homolog model | Resistance-nodulation-cell division (RND) antibiotic efflux pump | Fluoroquinolone antibiotic, tetracycline antibiotic | Antibiotic efflux | 42.26 | 98.96 | |
| Strict | adeF | Protein homolog model | Resistance-nodulation-cell division (RND) antibiotic efflux pump | Fluoroquinolone antibiotic, tetracycline antibiotic | Antibiotic efflux | 42.18 | 96.68 | |
| Loose | crmlv | Protein homolog model | Chloramphenicol phosphotransferase | Phenicol antibiotic | Antibiotic inactivation | 26.06 | 88.76 | |
| Stricta | Tet(41) | Protein homolog model | Major facilitator superfamily (MFS) antibiotic efflux pump | Tetracycline antibiotic | Antibiotic efflux | 9.49 | 98.98 |
FIGURE 2Survival of C. elegans on S. marcescens strains. Kaplan-Meier survival curve of C. elegans N2 nematodes fed Db11 (black circle, n = 90), CBS11 (black square, n = 90, p < 0.001), and CBS12 (open square, n = 90, p = 0.700). Survival curve is representative of one of three independent experiments.